naxitamab
y-mabs therapeutics
['naxitamab', 'y-mabs']
y-mabs announces presentation of naxitamab data at aacr - york, april 18, 2023 (globe newswire) -- y-mabs therapeutics, inc. (the company or y-mabs ) (nasdaq: ymab) a commercial-stage biopharmaceutical company focused on the development and commerc... 
CEO Of Digital Media Online